Abstract
CYP2C19 and CYP2E1 show great genetic differences between Orientals and Caucasians. The objective of this study was to investigate the genotype and allele distribution patterns of CYP2C19 and CYP2E1 polymorphisms among healthy participants in mainland Chinese Kazakh, Uygur and Han populations by the PCR–restriction fragment length polymorphism technique. The allele frequencies of CYP2C19*2, CYP2E1*5B and CYP2E1*6 were significantly lower in the Chinese Kazakh (15.4, 11.2 and 14.5%, respectively) (P<0.05) and Uygur (16.1, 12.1 and 18.8%) (P<0.05) populations than that in the Chinese Han population (28.8, 19.4 and 26.2%), but the frequencies of CYP2C19*3 were similar among the three populations (8.0, 9.4 and 7.2%). Frequencies of the three combined genotypes, one for predicted CYP2C19 poor metabolizers and two for predicted high levels of CYP2E1 transcription, were significantly lower in the Chinese Kazakh (7.5, 19.6 and 28.0%, respectively) (P<0.05, χ2-test) and Uygur (8.1, 22.8 and 33.6%) (P<0.05) populations compared with the Chinese Han population (16.5, 35.9 and 44.7%). The present research shows that frequencies of the functional single-nucleotide polymorphisms in the CYP2C19 and CYP2E1 genes vary in the Chinese Kazakh, Uygur and Han populations, suggesting that disease susceptibilities or drug responses associated with enzyme activities of CYP2C19 and CYP2E1 may differ in the diverse ethnic populations in mainland China.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Evans, W. E. Pharmacogenomics: marshalling the human genome to individualise drug therapy. Gut 52, ii10–ii18 (2003).
Griese, E. U., Ilett, K. F., Kitteringham, N. R., Eichelbaum, M., Powell, H., Spargo, R. M. et al. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia. Pharmacogenetics 11, 69–76 (2001).
Kóbori, L., Kõhalmy, K., Porrogi, P., Sárváry, E., Gerlei, Z., Fazakas, J. et al. Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism. Br. J. Clin. Pharmacol. 65, 428–436 (2008).
Bertilsson, L. Geographic/interracial differences in polymorphic drug oxidation: current state of the knowledge of cytochrome P450 (CYP) 2D6 and 2C19. Clin. Pharmacokinet. 29, 192–209 (1995).
Ghodke, Y., Joshi, K., Arya, Y., Radkar, A., Chiplunkar, A., Shintre, P. et al. Genetic polymorphism of CYP2C19 in Maharashtrian population. Eur. J. Epidemiol. 22, 907–915 (2007).
Shu, Y. & Zhou, H. H. Individual and ethnic differences in CYP2C19 activity in Chinese populations. Acta. Pharmacol. Sin. 21, 193–199 (2000).
Lee, S. S., Lee, S. J., Gwak, J., Jung, H. J., Thi-Le, H., Song, I. S. et al. Comparison of CYP2C19 genetic polymorphisms between Korean and Vietnamese populatons. Ther. Drug Monit. 29, 455–459 (2007).
Munaka, M., Kohshi, K., Kawamoto, T., Takasawa, S., Nagata, N., Itoh, H. et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 129, 355–360 (2003).
Verlaan, M., Te Morsche, R. H., Roelofs, H. M., Laheij, R. J., Jansen, J. B., Peters, W. H. et al. Genetic polymorphisms in alcohol metabolizing enzymes and chronic pancreatitis. Alcohol 39, 20–24 (2004).
Vidal, F., Lorenzo, A., Auguet, T., Olona, M., Broch, M., Gutiérrez, C. et al. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in spanish men: lack of association with alcoholism and alcoholic liver disease. J. Hepatol. 41, 744–750 (2004).
Li, D., Zhang, G. L., Lou, Y. Q., Li, Q., Wang, X. & Bu, X. Y. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. J. Clin. Pharm. Ther. 32, 89–95 (2007).
Niu, C. Y., Luo, J. Y. & Hao, Z. M. Genetic polymorphism analysis of cytochrome P450 2C19 in Chinese Uigur and Han populations. Chin. J. Dig. Dis. 5, 76–80 (2004).
Liou, Y. H., Lin, C. T., Wu, Y. J. & Wu, L. S. The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population. J. Hum. Genet. 51, 857–863 (2006).
Chen, L., Qin, S., Xie, J., Tang, J., Yang, L., Shen, W. et al. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China. Pharmacogenomics 9, 691–702 (2008).
Scordo, M. G., Caputi, A. P., D'Arrigo, C., Fava, G. & Spina, E. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmaco. Res. 50, 195–200 (2004).
Katsuyama, Y., Inoko, H., Imanishi, T., Mizuki, N., Gojobori, T. & Ota, M. Genetic relationships among Japanese, Northern Han, Hui, Uygur, Kazakh, Greek, Saudi Arabian, and Italian populations based on allelic frequencies at four VNTR (D1S80, D4S43, COL2A1, D17S5) and one STR (ACTBP2) Loci. Hum. Hered. 48, 126–137 (1998).
Makeeva, O., Stepanov, V., Puzyrev, V., Goldstein, D. B. & Grossman, I. Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes. Pharmacogenomics 9, 847–868 (2008).
Acknowledgements
This study was supported by the National Natural Science Foundation of China (Grants no. 30171097 and 30371665).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, SM., Zhu, AP., Li, D. et al. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations. J Hum Genet 54, 372–375 (2009). https://doi.org/10.1038/jhg.2009.41
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2009.41
Keywords
This article is cited by
-
Altered DNA methylation of CYP2E1 gene in schizophrenia patients with tardive dyskinesia
BMC Medical Genomics (2022)
-
Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations
The Pharmacogenomics Journal (2020)
-
Polymorphisms in genes involved in the absorption, distribution, metabolism, and excretion of drugs in the Kazakhs of Kazakhstan
BMC Genetics (2016)
